Expression of soluble antibody fragment by truncation of CH1 domain

Details for Australian Patent Application No. 2008261042 (hide)

Owner DOW GLOBAL TECHNOLOGIES INC.

Inventors Retallack, Diane; Mitchell, Jon C.

Agent Griffith Hack

Pub. Number AU-A-2008261042

PCT Pub. Number WO2008/151319

Priority 60/942,997 08.06.07 US

Filing date 6 June 2008

Wipo publication date 11 December 2008

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2008/151319 Priority application(s): WO2008/151319

28 January 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 21 Dec 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008261053-Procedures and compositions for reservoir protection

2008261030-T-cell cytokine-inducing surface molecules and methods of use